The Association for Accessible Medicines argued that a California law was trying to regulate business outside state borders.

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

The National Institutes of Health would slash funding for medical research doesn't make even cynical political sense. It's a ...

Controversy surrounded Him & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

The biotech industry’s DeepSeek moment came last fall.

Cutting them will significantly narrow the pipeline to future cures and drugs. Some of the biggest ... where the victims are too poor for pharmaceutical industry interest, like malaria.